(Q40102688)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23554239%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

meta-analysis

0 references

title

Meta-analysis of healing and prevention of digital ulcers in systemic sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23554239%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23554239%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

author name string

Theresa Tingey

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23554239%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Jenny Shu

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23554239%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Joseph Smuczek

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23554239%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

publication date

1 September 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23554239%20AND%20SRC:MED&resulttype=core&format=json

Arthritis Care and Research

27 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23554239%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23554239%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23554239%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

page(s)

1460-1471

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23554239%20AND%20SRC:MED&resulttype=core&format=json

The diagnosis and treatment of Raynaud's phenomenon: a practical approach.

27 February 2020

cites work

1 reference

Digital ulcers: overt vascular disease in systemic sclerosis

21 January 2018

1 reference

EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).

21 January 2018

1 reference

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time

21 January 2018

1 reference

Meta-analysis in clinical trials

21 January 2018

1 reference

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

Double-blind trial of CL115,347, a transdermally absorbed prostaglandin E2 analogue, in treatment of Raynaud's phenomenon.

21 January 2018

1 reference

A multiclinic, placebo-controlled, double-blind study of prostaglandin E1 in Raynaud's syndrome

21 January 2018

1 reference

Double-blind, multicenter controlled trial comparing topical dimethyl sulfoxide and normal saline for treatment of hand ulcers in patients with systemic sclerosis

21 January 2018

1 reference

Double-blind, placebo-controlled study of prazosin in Raynaud's phenomenon

21 January 2018

1 reference

Nifedipine in the treatment of Raynaud's phenomenon in patients with systemic sclerosis

21 January 2018

1 reference

Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis

21 January 2018

1 reference

Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study

21 January 2018

1 reference

Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.

21 January 2018

1 reference

Comparison between iloprost and alprostadil in the treatment of Raynaud's phenomenon

21 January 2018

1 reference

Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril

21 January 2018

1 reference

Efficacy of tadalafil in secondary Raynaud's phenomenon resistant to vasodilator therapy: a double-blind randomized cross-over trial

21 January 2018

1 reference

Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study

21 January 2018

1 reference

Two faces of the same coin: Raynaud phenomenon and digital ulcers in systemic sclerosis

21 January 2018

1 reference

Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis

21 January 2018

1 reference

Treatment of systemic sclerosis complications: what to use when first-line treatment fails--a consensus of systemic sclerosis experts

21 January 2018

1 reference

Management of Raynaud's phenomenon and digital ulcers in systemic sclerosis

21 January 2018

1 reference

Acquired factor VIII deficiency and polyradiculoneuropathy

21 January 2018

1 reference

Bosentan: a review of its use in the management of digital ulcers associated with systemic sclerosis

21 January 2018

1 reference

Long-term experience of bosentan for treating ulcers and healed ulcers in systemic sclerosis patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ACR.22018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23554239%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference